NEWS
Medical Dialogues | Abelacimab Effectively Prevents Postoperative Venous Thromboembolism: NEJM

Abelacimab is effective when administrated in patients after total knee arthroplasty for the prevention of venous thromboembolism, suggests a study published in The New England Journal of Medicine. There is very limited evidence for the exact role of factor XI in the pathogenesis of postoperative venous thromboembolism. Abelacimab is a monoclonal antibody that binds to […]

Life Science Leader | Back To The Office

Since lockdowns that began mid-Mar. 2020, remote work became the new norm for many, along with a new perspective. From the board room down to entry-level positions, knowledge workers suddenly saw their work and personal lives in a completely new light. More than a year later we hear the rallying cry that it is time […]

HPR | PolarityTE – SkinTE Regenerative Tissue Product

Dr. Ryan Mathis, MD, Vice President of Commercial Strategy at PolarityTE discusses SkinTE™ an innovative alternative for the treatment of chronic wounds, like diabetic foot ulcers (DFUs). He talks about the science behind SkinTE™, how it’s made of a patient’s own full-thickness skin, which retains the endogenous regenerative cellular populations found throughout his/her skin within multicellular segments. […]